News

Medigene highlights a new approach for neoantigen-specific TCRs at Neoantigen Summit 2016 in Boston

SHOW RELEASE

Medigene reports its results for the first nine months of 2016

SHOW RELEASE

Medigene participates at six national and international conferences

SHOW RELEASE

Medigene AG: bluebird bio and Medigene establish strategic T cell receptor (TCR) alliance in cancer immunotherapy

SHOW RELEASE

Medigene participates at five national and international conferences

SHOW RELEASE

Medigene publicizes new bioinformatics tool to predict potential cross-reactivity of cancer and virus antigens

SHOW RELEASE

Medigene reports outcome of Annual General Meeting

SHOW RELEASE

Medigene reports results of first six months 2016

SHOW RELEASE

Medigene participates at five upcoming international conferences

SHOW RELEASE

Medigene expands TCR platform technology with US patent for method for identification of CD4+ T cell antigens

SHOW RELEASE